1. (a) A psychiatric residential treatment facility shall report monthly on an approved Office of Long-Term Care template, to the state-designated protection and advocacy system, the office, and the resident’s PASSE, or the resident’s sending state the following data:

   1. (1) A resident is on four (4) or more psychotropic medications;
   2. (2) A resident is on two (2) or more concomitant stimulants (long-acting and an immediate release stimulant of the same chemical entity does not constitute concomitant prescribing);
   3. (3) A resident is on two (2) or more concomitant alpha agonists (long-acting and an immediate release alpha agonist of the same chemical entity does not constitute concomitant prescribing);
   4. (4) A resident is on two (2) or more concomitant antidepressants;
   5. (5) A resident is on two (2) or more concomitant antipsychotics;
   6. (6) A resident is on three (3) or more concomitant mood stabilizers;
   7. (7) A resident is on a psychotropic medication dose that exceeds usual recommended doses; and
   8. (8) A resident was administered a PRN.

2. (b) The monthly report must include justification for each item listed above, that outlines:

   1. (1) Why the therapeutic benefit outweighs the potential risk;
   2. (2) What additional oversight is being provided; and
   3. (3) On PRN orders the maximum dose allowed within twenty-four (24) hours and, also, maximum doses allowed per week shall be documented.

Codification Notes: "PASSE" means a Provider-Led Arkansas Shared Savings Entity.